410 related articles for article (PubMed ID: 29978303)
1. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation.
Salamonowicz M; Ociepa T; Frączkiewicz J; Szmydki-Baran A; Matysiak M; Czyżewski K; Wysocki M; Gałązka P; Zalas-Więcek P; Irga-Jaworska N; Drożyńska E; Zając-Spychała O; Wachowiak J; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Dembowska-Bagińska B; Chełmecka-Wiktorczyk L; Balwierz W; Bartnik M; Zielezińska K; Urasiński T; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Pierlejewski F; Młynarski W; Gamrot-Pyka Z; Woszczyk M; Małas Z; Badowska W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Gorczyńska E; Jermakow K; Król A; Chybicka A; Ussowicz M; Kałwak K; Styczyński J
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1805-1812. PubMed ID: 29978303
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
[TBL] [Abstract][Full Text] [Related]
4. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.
Akahoshi Y; Kimura S; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Clin Transplant; 2016 Jun; 30(6):703-8. PubMed ID: 27019071
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.
Vehreschild MJ; Weitershagen D; Biehl LM; Tacke D; Waldschmidt D; Töx U; Wisplinghoff H; Von Bergwelt-Baildon M; Cornely OA; Vehreschild JJ
Biol Blood Marrow Transplant; 2014 Jun; 20(6):823-8. PubMed ID: 24607558
[TBL] [Abstract][Full Text] [Related]
6. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
[TBL] [Abstract][Full Text] [Related]
10. Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with haematological malignancies in a tertiary care hospital in China.
Gu SL; Chen YB; Lv T; Zhang XW; Wei ZQ; Shen P; Li LJ
J Med Microbiol; 2015 Mar; 64(Pt 3):209-216. PubMed ID: 25596117
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
Barbar R; Hayden R; Sun Y; Tang L; Hakim H
Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
[TBL] [Abstract][Full Text] [Related]
12. Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant.
Agha A; Sehgal A; Lim MJ; Weber D; Hou JZ; Farah R; Raptis A; Im A; Dorritie K; Marks S; Agha M; Lim SH
Am J Hematol; 2016 Mar; 91(3):291-4. PubMed ID: 26661725
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
14. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies.
Zacharioudakis IM; Ziakas PD; Mylonakis E
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1650-4. PubMed ID: 24914822
[TBL] [Abstract][Full Text] [Related]
16. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
17. A case of multiple recurrence of Clostridium difficile infection with severe hematochezia in an immunocompromised host.
Zhang X; Chen Y; Gu S; Zheng B; Lv T; Lou Y; Jin J
Anaerobe; 2016 Dec; 42():31-32. PubMed ID: 27377777
[TBL] [Abstract][Full Text] [Related]
18. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.
Bruminhent J; Wang ZX; Hu C; Wagner J; Sunday R; Bobik B; Hegarty S; Keith S; Alpdogan S; Carabasi M; Filicko-O'Hara J; Flomenberg N; Kasner M; Outschoorn UM; Weiss M; Flomenberg P
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1329-34. PubMed ID: 24792871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
